|
Status |
Public on Dec 23, 2015 |
Title |
Comprehensive genomic analysis identify novel subtypes and targets of triple-negative breast cancer (67 not triple-negative tumors) |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Recent meta-analyses suggest triple-negative breast cancer (TNBC) is a heterogenous disease. In this study we sought to define these TNBC subtypes and identify subtype-specific markers and targets. We identified and confirmed four distinct, stable TNBC subtypes: (1) Luminal-AR (LAR); 2) Mesenchymal (MES); 3) Basal-Like Immune-Suppressed (BLIS), and 4) Basal-Like Immune-Activated (BLIA).
|
|
|
Overall design |
RNA profiling analyses were conducted on 198 TNBC tumors (ER-negativity defined as Allred Scale value ≤2) with >50% cellularity (discovery set: n=84; validation set: n=114) and 67 not triple-negative tumors.
|
|
|
Contributor(s) |
Burstein MD, Tsimelzon A, Hilsenbeck SG, Poage G, Covington K, Fuqua SA, Chang JC, Osborne CK, Mills GB, Lau CC, Brown PH |
Citation(s) |
25208879, 26921331 |
Submission date |
Dec 22, 2015 |
Last update date |
Mar 25, 2019 |
Contact name |
Suzanne Fuqua |
Organization name |
Baylor College of Medicine
|
Street address |
1 Baylor Plaza
|
City |
Houston |
State/province |
Texas |
ZIP/Postal code |
77030 |
Country |
USA |
|
|
Platforms (1) |
GPL570 |
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array |
|
Samples (67)
|
|
This SubSeries is part of SuperSeries: |
GSE76275 |
Comprehensive genomic analysis identify novel subtypes and targets of triple-negative breast cancer |
|
Relations |
BioProject |
PRJNA306765 |